Navigation Links
Herceptin and chemo improves response rates without major adverse effects in HER2 breast cancer
Date:4/18/2008

Berlin, Germany: Women with a particularly aggressive form of breast cancer seem to do better if they are treated with a combined anthracycline and taxane chemotherapy regimen before surgery, together with trastuzumab (Herceptin) before and after surgery, according to results from the largest multi-centre trial to investigate this treatment.

Professor Michael Untch told the 6th European Breast Cancer Conference (EBCC-6) in Berlin today (Friday) that the women in the trial did not suffer from any serious side effects of the treatment such as severe heart problems. These results are very challenging, as both trastuzumab and anthracyclines are associated with cardiac toxicity.

Prof Untch said: When we started this trial it was considered very courageous to give patients anthracyclines plus trastuzumab, but we wanted to expose patients to trastuzumab for as long as possible before surgery to make it as effective as possible. To minimise the risk, we excluded patients with any previous heart problems and excluded patients with ejection fractions of below 55%. However, our results showed no increase in toxicity for the combination chemotherapy plus trastuzumab compared with chemotherapy alone. There were no cases of congestive heart failure or cardiac-related deaths, and other cardiac-related symptoms were not severe. The combination chemotherapy plus trastuzumab proved to be the most effective combination, but, at the same time, we have to keep an eye on the heart. Therefore, cardiac monitoring every three months is a must for patients treated with this regimen.

A total of 1510 breast cancer patients were recruited to the GeparQuattro trial between 2006-2007; 453 of them had tumours that over-expressed the HER2 receptor (a particularly aggressive form of the disease). Before surgery they received four cycles of epirubicin/cyclophosphamide (EC) and were then randomised to receive either four cycles of docetaxel (D) or four cycles of D-capec
'/>"/>

Contact: Emma Mason
wordmason@mac.com
ECCO-the European CanCer Organisation
Source:Eurekalert

Page: 1 2

Related biology news :

1. UC health news: molecular pathway may predict chemotherapy effectiveness
2. A search for protection against chemotherapy cardiotoxicity
3. Standard chemo works better against metastatic BRCA1/2 breast cancer than against sporadic tumors
4. New chemotherapy combo produces side effects, but no extra efficacy, in early breast cancer patients
5. Exercise improves thinking, reduces diabetes risk in overweight children
6. Endobronchial valve significantly improves emphysema
7. Teamwork improves learning and career success
8. New clinical data shows chromium picolinate improves cognitive function
9. Stem-cell transplantation improves muscles in MD animal model, UT Southwestern researchers report
10. Key to out-of-control immune response in lung injury found
11. Flies can turn off their immune response
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... (NASDAQ: AMRI ) today reported financial and operating results for ... , Second quarter contract revenue of $ 85.2 ... Adjusted contract margins of 26 % , ... in EPS from royalties in the current quarter , ... are very pleased to present another strong financial quarter, with all ...
(Date:7/31/2015)... , Kina, 31. juli 2015 Den 10. ... afholdt af BGI fra den 22. - 25. oktober i ... Konferencen fejrer sin 10-års fødselsdag i år. Siden starten ... indflydelsesrige årlige møder på ,omik,-feltet, og er en af ... ICG-10 fokuserer på nylige gennembrud og fremskridt ...
(Date:7/31/2015)... , 31 de julho de 2015 A ... www.icg-10.org ) será realizada pela BGI de 22-25 de outubro ... A conferência está celebrando seu 10 o. ... a ICG se tornou uma das reuniões mais influentes ... encontros científicos mais dinâmicos, entusiastas e prazerosos. ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... BCh, of Mount Sinai Medical Center, New York was ... Genetics Fellowship in Biochemical Genetics at the ACMG 2008 ... objective of the Genzyme/ACMGF Award is to support a ... of clinicians in the field of clinical biochemical genetics ...
... may do it, but the microscopic animals called bdelloid rotifers ... Whats more, they have done so over millions of years ... creatures somehow escape the usual drawback of asexuality extinction ... their colleagues are finding out how. In two ...
... Conn.The environment will continue to deteriorate so long as ... argues Gus Speth, dean of the Yale School of ... Bridge at the Edge of the World: Capitalism, the ... Seeing an emerging environmental tragedy ...
Cached Biology News:Is DNA repair a substitute for sex? 2Is DNA repair a substitute for sex? 3Book examines clash of capitalism and the environment 2Book examines clash of capitalism and the environment 3
(Date:8/27/2015)... Calif. , Aug. 27, 2015  Asterias Biotherapeutics, ... the emerging field of regenerative medicine, today announced that ... conferences in the month of September.  ... present at Rodman & Renshaw,s 17th Annual Global Investment ... PT at the St. Regis Hotel in ...
(Date:8/27/2015)... Greifensee, Switzerland (PRWEB) , ... August 27, 2015 ... ... input on customers’ weighing needs and expertly narrows down the product choices to ... additional selection criteria pares down the list to models that fit best with ...
(Date:8/26/2015)... 2015  Roka Bioscience, Inc. (NASDAQ: ROKA ), ... solutions for the detection of foodborne pathogens, today announced ... Sidoti & Company Emerging Growth Conference on September 2 ... the New York Marriott Marquis. A ... the investor relations section of Roka Bioscience,s website at ...
(Date:8/26/2015)... and BEIJING , August 26, 2015 /PRNewswire/ ... with Impressive Acheivements  DiaCardio wins 1 st place  ... The competition, led in Israel by ... 21 startups from countries including the US, China ... and Latin America .  Impressive achievement ...
Breaking Biology Technology:Asterias Biotherapeutics to Present at Upcoming Investor Conferences 2METTLER TOLEDO Updates Online Scale Selection Tool 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 2Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 3Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 4Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 5Israeli Startup Takes First Place at Shengjing Global Innovation Awards 2015 6
... ... in health care has always been a statement on the order of "layoffs will not ... before that is unavoidable? MedZilla.com,s monthly employment report examines that trend, as well as announcing ... ...
... , ... factor and how is it addressed? International Sculptra trainer Dr. Rebecca Fitzgerald, known among her ... Volume Restoration to an internationally represented group of physicians at this year,s 4 day SDEF ... ...
... , PALO ALTO, Calif., July 21 ... groundbreaking personal ultrasound devices, announced today it has raised US$4 ... from Australian-based venture capital firms Brandon Capital Partners, Playford Capital, ... US$13 million to date. , ...
Cached Biology Technology:The MedZilla Report: June 2009 Employment Outlook for Biotech/Pharma/Health 2The MedZilla Report: June 2009 Employment Outlook for Biotech/Pharma/Health 3Looking Older Than You Are May Have Little to Do With Wrinkles 2Looking Older Than You Are May Have Little to Do With Wrinkles 3Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors 2Signostics Closes Follow-On Financing of US$4 Million, Expands Board of Directors 3
Removes polysaccharide and phenolic inhibitors of PCR; yields DNA greater than 50 kb in length...
Sf9 Insect Cells (Frozen) in Max-XP Medium...
HistoScan HRP Kit Universal Goat Kit...
One bottle containing 30 ml of protein solution and 0.1% sodium azide....
Biology Products: